TY  - JOUR
AU  - Romero, Alejandro
AU  - Ramos, Eva
AU  - Patiño, Paloma
AU  - Oset-Gasque, Maria J
AU  - Lopez-Muñoz, Francisco
AU  - Marco-Contelles, Jose
AU  - Ayuso, María I
AU  - Alcazar, Alberto
PY  - 2016
DO  - 10.3389/fnagi.2016.00281
SN  - 1663-4365
UR  - http://hdl.handle.net/10668/11259
T2  - Frontiers in aging neuroscience
AB  - Stroke is a disease of aging affecting millions of people worldwide, and recombinant tissue-type plasminogen activator (r-tPA) is the only treatment approved. However, r-tPA has a low therapeutic window and secondary effects which limit its beneficial...
LA  - en
PB  - Frontiers Research Foundation
KW  - melatonin
KW  - neuroprotection
KW  - nitrones
KW  - oxidative stress
KW  - stroke
KW  - Tissue Plasminogen Activator
KW  - Antioxidants
KW  - Melatonin
KW  - nitrones
KW  - Neuroprotection
KW  - Stroke
KW  - Aging
KW  - Free Radicals
TI  - Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.
TY  - research article
VL  - 8
ER  -